Bio-Rad Defends Labeling Under First Amendment, Prior FDA Inaction
This article was originally published in The Gray Sheet
Executive Summary
Disclaimers on unified labeling for lab "control products" that list unapproved tests are legal and do not promote off-label use, Bio-Rad maintains in a citizen petition recently filed with FDA